Bio-Rad Laboratories | BIO - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Abbott USD 6.8B 1.72B 2026-03
Agilent USD 1.76B 31M 2025-12
Becton, Dickinson and Co. USD 813M 73M 2026-03
Bio Techne USD 209.82M 36.94M 2026-03
Bio-Rad Laboratories USD 507.2M 22.6M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Charles River Laboratories USD 191.83M 21.94M 2026-03
Danaher USD 5.7B 1.09B 2026-03
General Electric Aerospace USD 10.98B 1.41B 2026-03
Illumina USD 1.42B 368M 2025-12
IQVIA Holdings USD 1.95B 33M 2026-03
Laboratory Of America USD 981.1M 448.8M 2026-03
Merck USD 5.33B 9.24B 2026-03
Mettler Toledo International USD 66.89M 2.18M 2025-12
Myriad Genetics USD 124.4M 25.2M 2026-03
OraSure Technologies USD 176.96M 22.31M 2026-03
Pacific Biosciences Of California USD 56.27M 223.23M 2026-03
Quest Diagnostics USD 393M 27M 2026-03
Repligen USD 582.65M 16.63M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Roche Holding CHF 7.55B 579M 2025-06
Siemens EUR 14.5B 146M 2025-09
Standard Biotools USD 265.77M 147.56M 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Tosoh JPY 133.1B 10.44B 2025-09
Waters USD 462M 125.83M 2026-03